European Journal of Biomedical and Pharmaceutical Sciences

A REVIEW ON THE NOVEL COVID-19 VACCINE: TYPES OF VACCINE PLATFORMS

Ruthika Ratnaveni Marri, Mamatha Tirunagari*, Prasanthi Raghavarapu, Nida Tahreen, Siva Jyothi Buggana

ABSTRACT

The mishap of the peculiar severe acute respiratory syndrome by coronavirus, SARS-CoV-2 is still a worldwide human setback. So far, no particular antiviral drug or therapy has been capable to break the extensive SARS-CoV-2. During this span, a phenomenal effort by the scientific coterie has led to the evolution of over 300 vaccine projects. Out of which 40 vaccines are subjected to the clinical evaluation and around 10 vaccines are going through phase 3 clinical trials also three vaccines have winded up the phase 3 clinical trials with effective results. In addition to these a couple of vaccines were consented for emergency use. It has been basically presumed that reviving protective immunity through the universal vaccination is a discrete strategy to survive this pandemic. To ease the consequence of the virus on the world’s population and the international wealth vaccines were rapidly evolved. In not more than a year corresponding to usual clinical development rules, many vaccines were released on the market and many vaccine drives were brought into action. To develop a vaccine, it is necessary to know the patient’s well-being associated behaviours and perceptions to manage the public health vaccination policy. It also involves attention towards the immunological and non-immunological perspective.

Keywords: SARS-CoV-2 vaccinations, Technological problems, Vaccine drives, Clinical Trials, Efficacy, Types of vaccines, Perceptions, Immunological and non-immunological.